This Week in Nature

In Nature this week, researchers from the University of Bonn and the University of California, Los Angeles, describe the use of a genetically engineered mouse to how melanomas become resistant to treatment. Adoptive cell therapies, which fight tumors with cytotoxic T cells, are often initially effective in treating melanoma, but patients frequently relapse.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Women with breast or ovarian cancer living in medically underserved regions of the US are less likely to get recommended BRCA1 or BRCA2 genetic testing, according to a new study.

Three immunology researchers are to receive this year's Albany Medical Center Prize in Medicine and Biomedical Research, the Albany Times-Union reports.

Elephants may have "re-animated" a pseudogene to help stave off cancer, according to the New York Times.

In Genome Research this week: clonal evolution analysis of acute myeloid leukemia, computational pipeline to examine relationships between bacterial pathogens, and more.